AI assistant
BOSTON SCIENTIFIC CORP — Director's Dealing 2020
Feb 19, 2020
29821_dirs_2020-02-19_3cc56bdd-10c9-47bd-b4a9-8a11012ecc54.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2020-02-18
Reporting Person: Ballinger Kevin J. (EVP & Pres, Interven Cardio)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-02-19 | Common Stock | S | 1757.0000 | $42.3100 | Disposed | 95868.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-02-18 | Deferred Stock Units | $ | A | 12452.0000 | Acquired | 2024-02-18 | Common Stock (12452.0000) | Direct |
| 2020-02-18 | Stock Option (Right to Buy) | $42.1600 | A | 46460.0000 | Acquired | 2030-02-18 | Common Stock (46460.0000) | Direct |
Footnotes
F1: This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan.
F2: Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.
F3: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F4: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 18, 2021, the first anniversary of the date of grant.
F5: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 18, 2021, the first anniversary of the date of grant.